Transgenic mice constitutively overexpressing ATIP1 under the control of the CMV promoter did not have increased blood pressure or any signs of cardiac hypertrophy, which is in contrast to our mouse model of ATIP1 deficiency [24]. Here, MTUS1 is linked to cardiac hypertrophy.